ENTITY
Sosei Group

Sosei Group (4565 JP)

31
Analysis
Health CareJapan
Sosei Group Corporation is a holding company which was established through reorganization. The Group companies are biopharmaceutical companies specializing in drug development. Sosei Group enters into license agreements primarily with US, EU, and Japanese companies to market the licensed drugs in Japan and find alternative usage on such drugs.
more
Refresh
bullishSosei Group
17 Nov 2017 02:10

Sosei Placement - One-Year Return for Its 2015 Equity Raise Was 354%

Sosei Group Corp (4565 JP) is looking to raise US$204m by selling about 2m primary shares. Proceeds raised will be used to fund drug discovery and...

Share
bullishSosei Group
16 Nov 2017 02:42

Sosei Offering: Company History, Earnings Structure, Business Model and Use of Proceeds

On 10 Nov 2017 Sosei Group Corp (4565 JP) announced an overseas offering for 2.07m new shares (1.8m + 0.27m overallotment option). The offering...

Logo
Mio Kato
176 Views
Share
27 Jul 2017 07:30

Mitsubishi Tanabe (4508) - Acquisition of NeuroDerm Playing to Strength, Not Weakness

The history of overseas acquisitions by Japanese drug companies is not a pretty one, as they've either overpaid for a skillset (Takeda (4502 JP)...

bullishAstellas Pharma
25 Jul 2017 13:18

Update on Astellas (4503) As It Gets Orphan Drug Status for Gilteritinib

News that gilteritinib has received orphan drug status for acute myeloid leukaemia (AML) would be rather more exciting for Astellas (4503 JP) but...

bullishTDK Corp
20 Jun 2017 04:36

Cambridge Mechatronics Limited (CML) - A Name to Remember

As a UK-based company specializing in listed Japanese technology funds, it is always exciting to find companies in your own back yard making their...

x